Clinical Trial Update: Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating SGLT2 inhibitors in patients experiencing a heart attack (ST-elevation myocardial infarction) and cardiomegaly. Enrollmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomegaly
• Myocardial Infarction

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: Minneapolis Heart Institute Foundation | Conditions: Heart Attack, Enlarged Heart | Phase 2 | Status: RECRUITING